<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GAB-Z-MOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact in the Gabonese Republic - Gabon (01-Jan-2025-31-Dec-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Gabon, Multicomponent, Ministry of Health of the Gabonese Republic</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Réduire les nouvelles infections du VIH de 95% d'ici 2027 / Reduce new HIV infections by 95% by 2027; Réduire le taux de transmission du VIH de la mère à l'enfant de 13% à 7% d'ici 2027  / Reduce the rate of mother-to-child transmission of HIV from 13% to 7% by 2027; Réduire le nombre des décès liés au VIH de 95% d'ici 2027 / Reduce HIV-related deaths by 95% by 2027; Assurer la protection sociale, le soutien, le respect des droits humains, du genre et de l'équité dans la réponse nationale au VIH / Ensure social protection, support, respect for human rights, gender and equity in the national response to HIV; D’ici 2027, contribuer à une réduction 7% de l’incidence liée à la tuberculose au Gabon c'est-à-dire passer d’une incidence de 509 cas en 2022 à 480 cas pour 100 000 habitants / By 2027, contribute to a 7% reduction in the incidence of tuberculosis in Gabon, i.e. go from an incidence of 509 cases in 2022 to 480 cases per 100,000 inhabitants; D’ici 2027, contribuer à la réduction de la mortalité de 80 décès pour 100 000 habitants en 2022  à 71 décès/100,000 habitants dues à la tuberculose. / By 2027, contribute to the reduction of mortality from 80 deaths per 100,000 inhabitants in 2022 to 71 deaths/100,000 inhabitants due to tuberculosis; D’ici 2027, réduire d’au moins 65%, l’incidence et la mortalité liées au paludisme par rapport à 2021 / By 2027, reduce at least 65% of malaria incidence and mortality compared to 2021. Objectives: Reduire les nouvelles infections  au VIH de 1900 en 2022 à 816 en 2027 / Reduce new HIV  infections from 1900 in 2022 to 816 in 2027; Reduire la mortalité liée au VIH de 1800 décès en 2022 à 800 en 2027 /Reduce HIV-related mortality from 1,800 deaths in 2022 to 800 in 2027; Augmenter la notification des cas de tuberculose nouveaux cas et rechutes de tuberculose de 6575 en 2023 à 10157 en 2027 et avoir un succés thérapeutique pour 86% des cas mis sous traitement / Increase the notification of new cases and relapses of tuberculosis from 6,575 in 2023 to 9,399 in 2027 and have therapeutic success for 86% of cases put under treatment; Augmenter de 90 cas de TB-RR et ou TB-MR en 2022 à 222 cas en 2027 la notification des patients annuellement mis sous traitement pour une tuberculose multi-résistante ou résistante à la rifampicine et atteindre un taux de succès thérapeutique d'au moins 63% en 2027. / Increase from 90 cases of RR-TB and/or MDR-TB in 2022 to 222 cases in 2027 the notification of patients annually placed on treatment for multi-drug-resistant or rifampicin-resistant tuberculosis and achieve a therapeutic success rate of at least 63% in 2027; Effectuer en 2027 le depistage VIH chez 92% des nouveaux cas et rechutes et mettre sous therapie préventive au moins 10% des personnes vivant avec le VIH éligible. / Carry out HIV screening in 92% of new cases and relapses in 2027 and put at least 10% of eligible people living with HIV on preventive therapy; Augmenter le pourcentage des patients atteints de TB enregistrés nouveaux cas et rechutes dont le statut sérologique VIH est documenté, de 53% en 2023 à 92% en 2027 / Increase the percentage of TB patients registered new cases and relapses whose HIV serological status is documented, from 53% in 2023 to 92% in 2027.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the Gabonese Republic</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the Gabonese Republic</narrative>
    </participating-org>
    <other-identifier ref="GAB-Z-MOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-01-01" />
    <activity-date type="2" iso-date="2025-01-01" />
    <activity-date type="3" iso-date="2027-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Plaikessi Kouadjani</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>plaikessi.kouadjani@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GA" percentage="100">
      <narrative>Gabon</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="33.59">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="33">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="18.37">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="15.04">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="2.1">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="1.03">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="4.21">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.29">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="10.65">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="33">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.8">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="11.44">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="1.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="0.28">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="9.66">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="1.64">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="3.69">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="0ed16776-d36f-4d43-a8fc-294a23927ba7" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy, including support to TB survivor-led groups</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="7.21">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="1.31">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.44">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d98eb915-d64b-45bb-8bae-93a530d37d6e" percentage="4.23">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Community care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="4.85">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1793355.98</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">3699725.14</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">1303057.99</value>
    </budget>
    <capital-spend percentage="4.64" />
    <transaction ref="6f4baa9d-5f2a-428b-91bc-164be812b312">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-03" />
      <value currency="USD" value-date="2024-12-03">4656977.73</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3192e95d-8290-4809-9970-71da30e049f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">728591.63</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f029db97-b609-42e6-a4fe-9f0eb563e873">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-20" />
      <value currency="USD" value-date="2025-02-20">158879.12</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="031cf286-1043-40d1-b45f-9c80ba5a6fad">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-11" />
      <value currency="USD" value-date="2025-03-11">85807.89</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0fb7fc02-0789-4648-a2f5-be228bf9f016">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">9291.54</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="38b7b1b4-7931-425e-8b9b-531931af0b83">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">158517.03</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0f00b8bb-8701-4579-867c-4f44080f8125">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">159770.07</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9895a9a4-a073-43c4-81c2-245f094ffb20">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-11" />
      <value currency="USD" value-date="2025-07-11">325525.49</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="680e2135-693c-4ae5-a7b4-b3918db3d445">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-11" />
      <value currency="USD" value-date="2025-07-11">-159770.07</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd43a5a3-6293-47be-8fd1-32b6a703b003">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">69810.23</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d911e1f1-f2ff-4b36-ba0f-3975db540174">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">-325525.49</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83b0db75-f5ee-48b3-aafc-21c7d17fec6b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">641124.28</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4318249e-14cc-4e36-9cd0-4ca758221346">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-07" />
      <value currency="USD" value-date="2025-08-07">-641124.28</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ab4a3731-2a42-4c80-aaf8-3a47ee8b58ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-07" />
      <value currency="USD" value-date="2025-08-07">641127.09</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b902f2a1-7319-465a-b2ff-0663f7700969">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">187.12</value>
      <description>
        <narrative>Funds returned to the Global Fund from GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f92ef5a8-9a45-4d17-808e-31711827f9c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-15" />
      <value currency="USD" value-date="2025-09-15">-187.12</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b3e06c1-b19a-473b-9ef8-7a88482ceb3f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-04" />
      <value currency="USD" value-date="2025-10-04">639433.80</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9db94bd5-b51a-406c-ae33-09e9a4114521">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-04" />
      <value currency="USD" value-date="2025-10-04">-641127.09</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a153103c-5091-4521-b316-e7b894fe128f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">145463.03</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="00b6d0ad-443e-4c12-9adb-b70238617cf4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-31" />
      <value currency="USD" value-date="2025-10-31">-369124.81</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4978ffa-9fa5-4741-ae1b-d5d6377a8bff">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-31" />
      <value currency="USD" value-date="2025-10-31">369105.64</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56b724e3-9acc-4c6a-b49f-4c7479e2c9e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">124845.96</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="860453d7-dbbd-49a9-8316-d3a1b5e92bf9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">53694.46</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f739d107-a8f6-406e-bb3e-03b2b5d04080">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">35645.28</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="95376edc-2e25-4785-8a85-8977be3483ec">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">867.86</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ad918bf6-656d-41c9-bede-d7c1f9cfdc43">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">3585.12</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f18cd416-c3fb-4825-87be-d4b232ce080a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">265541.96</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="841b3050-728a-4cb0-be00-3bcaf7c07345">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-275312.94</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e93ec306-804c-4d77-b992-2624bfab4b2c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">261739.26</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="609c22f3-bc79-471d-b9c9-2f948cf98719">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">-265541.96</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f154d318-76d9-4814-a4fd-f7fa9a038a49">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">13157.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="623c77ac-ef36-4259-b1a4-a6538a9bd46b">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-09" />
      <value currency="USD" value-date="2026-03-09">6288.53</value>
      <description>
        <narrative>Funds returned to the Global Fund from GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="695fe7b9-677d-4cee-a6f3-5859da1b53a2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-13157.97</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4968a493-fa6a-4b2b-906e-748c3cc3e04c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-6288.53</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cf34ef39-88f6-4f62-a921-430fbb5521d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-20" />
      <value currency="USD" value-date="2026-03-20">286258.41</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9aa91048-378a-4fa8-9b36-f49439f500a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-20" />
      <value currency="USD" value-date="2026-03-20">-24519.15</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="714f89a4-47d4-4c2e-934a-99144ce71e5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-20" />
      <value currency="USD" value-date="2026-03-20">-261739.26</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="abcb4887-df4b-4238-9caf-ac208cd956c0">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-25" />
      <value currency="USD" value-date="2026-03-25">24519.15</value>
      <description>
        <narrative>Funds returned to the Global Fund from GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84711699-d937-4f0e-8613-56bd5f431d4a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">-286258.41</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e45d8ee-929d-4c3c-8622-f9d3ac812a20">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">55742.11</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85346c75-ed05-4f24-a494-4c80cf0c419c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">8703.43</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a5086de9-478a-4191-bf30-ec3d3c49c23d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">44900.35</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="34364be5-47c3-46d3-8457-8558de46083a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">217155.62</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10513900-2a8a-4ddb-a5d3-311ab3e7b657">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-20" />
      <value currency="USD" value-date="2026-05-20">134054.92</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6359bfac-2738-41fe-8c4c-c452355ea371">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-20" />
      <value currency="USD" value-date="2026-05-20">-10841.76</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5b060e8-8998-40fd-8a6b-b94fca311de4">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">141992.03</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94fd0fbd-5a14-4f89-bd2e-4d4503b95e58">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">-134054.92</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd5b1dc1-4f2b-406b-8545-ceab4215003f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">133475.30</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6f9e82ed-c697-485a-8cb3-4b12f028d352">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">-141992.03</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="35c215d8-19e8-4df7-ad65-1e15df8a9dec">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-03" />
      <value currency="USD" value-date="2026-07-03">134616.63</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bcb08812-ff1a-49b0-9194-dc26f18801cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-03" />
      <value currency="USD" value-date="2026-07-03">-133475.30</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="93c8e151-5038-492a-829c-84dc7665e568">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">263875.79</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fe8527a-21d2-40d2-846a-506a2299b54c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">-134616.63</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fba9b66e-1cb8-4802-9be5-75999a0a02fb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">108721.58</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7fc2f80d-a4c4-4b5d-b2e8-14f9b340be2d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">-155154.21</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="81f22b13-a552-4976-8c8f-6b38fcddf5bf">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">171310.66</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5877f9b2-ec0c-4fae-8595-326c4a8ca4e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">170704.99</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="60f03fda-fb36-4f09-8956-6087f9126e5f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">-171310.66</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3dbba2a-9b94-4a99-9193-ffe022484066">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-20" />
      <value currency="USD" value-date="2026-09-20">3424172.78</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9e9ae7a9-0a38-4e1a-b417-a88697b48a26">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-20" />
      <value currency="USD" value-date="2026-09-20">-3220221.24</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eb76d8d6-183f-462b-aa49-9dac6748c6a4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">2524641.26</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="450321d1-03fa-47cc-9191-fcb4eae6afc6">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">13530.50</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="399a1e29-e4b1-4129-aec3-b1ef6259cd39">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">101225.55</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0b7b427-9843-4a8d-8105-5b0ce3fde969">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">5648.67</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c6131ddd-8488-4865-8669-5193b7947b83">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">3275.54</value>
      <description>
        <narrative>Funds returned to the Global Fund from GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25ed5d43-6229-4189-8881-e69ec432aa16">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">8088.02</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="65fa74a9-f421-415a-91c4-60e35294b353">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">35839.91</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="919a0210-f3ab-47c7-a3c1-b130202946cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">9321.44</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c0032373-ee62-40fd-ba70-a8bbe83f2984">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">-3275.54</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec4544cb-38b3-4489-9e76-d18a9dd17cf9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">4380.37</value>
      <description>
        <narrative>Global Fund disbursement to GAB-Z-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="64ae1abe-f508-4ecd-8dd0-a1c27d62787a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">95237.40</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="68c9dac9-d0f7-4289-b9e7-096d661f72c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">-99544.75</value>
      <description>
        <narrative>Global Fund commitment to GAB-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GAB-Z-MOHP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">1429353.73</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Gabonese Republic for GAB-Z-MOHP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Gabonese Republic</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GAB-Z-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GAB/2024/Multi-Component/en/GAB-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - Gabon - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1623-GAB-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GAB/2024/Multicomponent/fr/GAB-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - Multicomponent - Gabon - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1623-GAB-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 1,602,855 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.1(1)(a) and 6.1(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in “Engagement des gouvernements relatif au cofinancement des ripostes nationales soutenues par Ie Fonds Mondial”, dated 12 September 2024 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of EUR 17,569,424 from 2025-2027 (inclusive), comprising investments in: i. HIV of EUR 4,686,261; ii. TB of EUR 5,126,190; and iii. Malaria of EUR 7,756,973; (b) fulfil the programmatic commitments as stipulated in Table 3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 31 March of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for HIV / TB / Malaria for the upcoming year; and ii. the total expenditure for HIV / TB / Malaria in the previous fiscal year. (d) The Grantee shall, as set out in Section 4 of the Commitment Letter, provide evidence to the Global Fund of an approved budget allocation for financing 100% of the procurement of universal insecticide-treated mosquito nets (ITN) and associated shipping and handling costs amounting to EUR 7,125 964 to conduct the ITN mass distribution campaign (the "ITN Mass Campaign"). i. Subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.1 (2) (d), and without prejudice to the terms and conditions of this Grant Agreement, the Principal Recipient acknowledges that the Global Fund will match up to 50% of the total cost of the ITN Mass Campaign, (i.e. up to EUR 3,220,800), in accordance with international best practices, as outlined by the World Health Organization (WHO) and the Alliance for Malaria Prevention (AMP).</narrative>
      </condition>
      <condition type="3">
        <narrative>2 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form approved by the Global Fund.</narrative>
      </condition>
      <condition type="3">
        <narrative>3 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient consents to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2025, 2026 and 2027 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing, and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
      <condition type="3">
        <narrative>4 - No later than 30 April 2025, the Principal Recipient shall submit to the Global Fund and obtain the Global Fund’s prior written approval of a procedures manual that shall describe in detail the following, without limitation: (1) the roles and responsibilities of Program staff; (2) recruitment procedures for Program staff; (3) disbursement procedures to Sub-recipients and Suppliers; and (4) procurement procedures for Program goods and services.</narrative>
      </condition>
      <condition type="2">
        <narrative>5 - No later than 30 September 2025, the Principal Recipient shall submit to the Global Fund and obtain the Global Fund’s prior written approval of, an updated national monitoring and evaluation plan.</narrative>
      </condition>
      <condition type="2">
        <narrative>6 - Prior to the use of budget lines 37, 44 and 49 of the Grant budget by the Principal Recipient to treat DR-TB patients activities, to procure a generator for the Nkembo Hospital and for the mapping and the biological and behavioral survey for key populations, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, a detailed budget and implementation plan for these activities.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="118" />
        <baseline year="2023" iso-date="2023-12-31" value="115">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="3">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="14">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="104">
          <dimension name="Gender" value="Male" />
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="186" />
          <actual value="99" />
          <actual value="94">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="5">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="40">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="59">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="204" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="222" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 107; Denominator: 118; Percentage: 90.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 105; Denominator: 107; Percentage: 98.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 107; Percentage: 1.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 43; Denominator: 107; Percentage: 40.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 107; Percentage: 59.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 84; Denominator: 107; Percentage: 78.5%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 186; Denominator: 186; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 92; Denominator: 99; Percentage: 92.93%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 89; Denominator: 92; Percentage: 96.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 92; Percentage: 3.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 39; Denominator: 92; Percentage: 42.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 53; Denominator: 92; Percentage: 57.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 79.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 204; Denominator: 204; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 222; Denominator: 222; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="52.17">
          <comment>
            <narrative>Numerator: 36; Denominator: 69.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="59.33">
            <comment>
              <narrative>Numerator: 89; Denominator: 150.</narrative>
            </comment>
          </target>
          <actual value="60.78">
            <comment>
              <narrative>Numerator: 31; Denominator: 51.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="60.71">
            <comment>
              <narrative>Numerator: 102; Denominator: 168.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="62.9">
            <comment>
              <narrative>Numerator: 117; Denominator: 186.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="34.67">
          <comment>
            <narrative>Numerator: 742; Denominator: 2140.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="49.9">
            <comment>
              <narrative>Numerator: 1031; Denominator: 2066.</narrative>
            </comment>
          </target>
          <actual value="16.52">
            <comment>
              <narrative>Numerator: 380; Denominator: 2300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="55.61">
            <comment>
              <narrative>Numerator: 1120; Denominator: 2014.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="64.05">
            <comment>
              <narrative>Numerator: 1258; Denominator: 1964.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="65">
          <comment>
            <narrative>Numerator: 23828; Denominator: 36659.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 30953; Denominator: 41271.</narrative>
            </comment>
          </target>
          <actual value="77.08">
            <comment>
              <narrative>Numerator: 26841; Denominator: 34822.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 37105; Denominator: 46381.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 47386; Denominator: 55748.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="6575" />
        <baseline year="2023" iso-date="2023-12-31" value="6300">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="275">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="3957">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="2418">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="4157">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="2501">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="985">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="3089">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8069" />
          <actual value="6598" />
          <actual value="6348">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="250">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="4243">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="2301">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="4297">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="1701">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="991">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="3906">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="8737" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="9399" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="38.28">
          <comment>
            <narrative>Numerator: 2411; Denominator: 6299.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 3631; Denominator: 8069.</narrative>
            </comment>
          </target>
          <actual value="62.81">
            <comment>
              <narrative>Numerator: 4144; Denominator: 6598.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 5242; Denominator: 8737.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 7049; Denominator: 9399.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="5.11">
          <comment>
            <narrative>Numerator: 336; Denominator: 6575.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="9.73">
            <comment>
              <narrative>Numerator: 850; Denominator: 8737.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="10.81">
            <comment>
              <narrative>Numerator: 1016; Denominator: 9399.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="65.35">
          <comment>
            <narrative>Numerator: 2348; Denominator: 3593.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="74">
            <comment>
              <narrative>Numerator: 5940; Denominator: 8027.</narrative>
            </comment>
          </target>
          <actual value="72.5">
            <comment>
              <narrative>Numerator: 2138; Denominator: 2949.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 6455; Denominator: 8069.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="86">
            <comment>
              <narrative>Numerator: 7514; Denominator: 8737.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="93.6">
          <comment>
            <narrative>Numerator: 922; Denominator: 985.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="94.38">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 907; Denominator: 961.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="58.82">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 10; Denominator: 17.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="71.43">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 5; Denominator: 7.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="92.22">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 498; Denominator: 540.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="95.28">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 424; Denominator: 445.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 1619; Denominator: 1704.</narrative>
            </comment>
          </target>
          <actual value="77.9">
            <comment>
              <narrative>Numerator: 772; Denominator: 991.</narrative>
            </comment>
          </actual>
          <actual value="77.95">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 760; Denominator: 975.</narrative>
            </comment>
          </actual>
          <actual value="90.91">
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 10; Denominator: 11.</narrative>
            </comment>
          </actual>
          <actual value="40">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 2; Denominator: 5.</narrative>
            </comment>
          </actual>
          <actual value="80.04">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 405; Denominator: 506.</narrative>
            </comment>
          </actual>
          <actual value="75.67">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 367; Denominator: 485.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95.95">
            <comment>
              <narrative>Numerator: 2040; Denominator: 2126.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="96.99">
            <comment>
              <narrative>Numerator: 2512; Denominator: 2590.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="6.17">
          <comment>
            <narrative>Numerator: 1769; Denominator: 28659.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="8.4">
            <comment>
              <narrative>Numerator: 3086; Denominator: 36737.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="9.8">
            <comment>
              <narrative>Numerator: 3844; Denominator: 39222.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="53.02">
          <comment>
            <narrative>Numerator: 3486; Denominator: 6575.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70.38">
            <comment>
              <narrative>Numerator: 5679; Denominator: 8069.</narrative>
            </comment>
          </target>
          <actual value="40.8">
            <comment>
              <narrative>Numerator: 2692; Denominator: 6598.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="81.09">
            <comment>
              <narrative>Numerator: 7085; Denominator: 8737.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="91.85">
            <comment>
              <narrative>Numerator: 8633; Denominator: 9399.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="24.01">
          <comment>
            <narrative>Numerator: 543; Denominator: 2262.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="41.98">
            <comment>
              <narrative>Numerator: 767; Denominator: 1827.</narrative>
            </comment>
          </target>
          <actual value="31.96">
            <comment>
              <narrative>Numerator: 767; Denominator: 2400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="49.01">
            <comment>
              <narrative>Numerator: 815; Denominator: 1663.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 836; Denominator: 1520.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="34.33">
          <comment>
            <narrative>Numerator: 9838; Denominator: 28659.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="26.32">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 265; Denominator: 1007.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="90.16">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 669; Denominator: 742.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="9.84">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 73; Denominator: 742.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65.17">
            <comment>
              <narrative>Numerator: 22239; Denominator: 34125.</narrative>
            </comment>
          </target>
          <actual value="25.91">
            <comment>
              <narrative>Numerator: 9156; Denominator: 35334.</narrative>
            </comment>
          </actual>
          <actual value="25.55">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 8874; Denominator: 34730.</narrative>
            </comment>
          </actual>
          <actual value="46.69">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 282; Denominator: 604.</narrative>
            </comment>
          </actual>
          <actual value="28.33">
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 2934; Denominator: 10358.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 27553; Denominator: 36737.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 33338; Denominator: 39222.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="58.77">
          <comment>
            <narrative>Numerator: 28569; Denominator: 48614.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="67">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 19141; Denominator: 28569.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="31.1">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 8885; Denominator: 28569.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="68.9">
            <comment>
              <narrative>Numerator: 34125; Denominator: 49527.</narrative>
            </comment>
          </target>
          <actual value="67.95">
            <comment>
              <narrative>Numerator: 35334; Denominator: 52000.</narrative>
            </comment>
          </actual>
          <actual value="69.81">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 24672; Denominator: 35344.</narrative>
            </comment>
          </actual>
          <actual value="30.17">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10662; Denominator: 35344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="74.09">
            <comment>
              <narrative>Numerator: 36737; Denominator: 49587.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="79">
            <comment>
              <narrative>Numerator: 39222; Denominator: 49645.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="82.1">
          <comment>
            <narrative>Numerator: 1757; Denominator: 2140.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="86.01">
            <comment>
              <narrative>Numerator: 1777; Denominator: 2066.</narrative>
            </comment>
          </target>
          <actual value="80.26">
            <comment>
              <narrative>Numerator: 1846; Denominator: 2300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="88.98">
            <comment>
              <narrative>Numerator: 1792; Denominator: 2014.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="90.99">
            <comment>
              <narrative>Numerator: 1787; Denominator: 1964.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="14130" />
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1423643" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>